How national leaders keep 'us' safe: A longitudinal, four-nation study exploring the role of identity leadership as a predictor of adherence to COVID-19 non-pharmaceutical interventions.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
10 05 2022
Historique:
entrez: 10 5 2022
pubmed: 11 5 2022
medline: 14 5 2022
Statut: epublish

Résumé

To investigate whether citizens' adherence to health-protective non-pharmaceutical interventions (NPIs) during the COVID-19 pandemic is predicted by identity leadership, wherein leaders are perceived to create a sense of shared national identity. Observational two-wave study. Hypotheses testing was conducted with structural equation modelling. Data collection during the COVID-19 pandemic in China, Germany, Israel and the USA in April/May 2020 and four weeks later. Adults in China (n=548, 66.6% women), Germany (n=182, 78% women), Israel (n=198, 51.0% women) and the USA (n=108, 58.3% women). Identity leadership (assessed by the four-item Identity Leadership Inventory Short-Form) at Time 1, perceived shared national identification (PSNI; assessed with four items) and adherence to health-protective NPIs (assessed with 10 items that describe different health-protective interventions; for example, wearing face masks) at Time 2. Identity leadership was positively associated with PSNI (95% CI 0.11 to 0.30, p<0.001) in all countries. This, in turn, was related to more adherence to health-protective NPIs in all countries (95% CI 0.03 to 0.36, 0.001≤ National leaders can make a difference by promoting a sense of shared identity among their citizens because people are more inclined to follow health-protective NPIs to the extent that they feel part of a united 'us'. However, the content of identity leadership (perceptions of what it means to be a nation's citizen) is essential, because this can also encourage people to disregard such recommendations.

Identifiants

pubmed: 35537783
pii: bmjopen-2021-054980
doi: 10.1136/bmjopen-2021-054980
pmc: PMC9091491
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e054980

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Psychol Sci. 2007 Mar;18(3):233-9
pubmed: 17444920
Proc Natl Acad Sci U S A. 2021 Jun 8;118(23):
pubmed: 34016707
Sci Rep. 2021 May 19;11(1):10605
pubmed: 34012040
BMJ. 2013 Feb 26;346:f653
pubmed: 23444424
JMIR Public Health Surveill. 2020 May 28;6(2):e19862
pubmed: 32434145
Soc Issues Policy Rev. 2021 Jan;15(1):35-83
pubmed: 33821168
Int J Intercult Relat. 2021 Mar;81:1-8
pubmed: 33518841
Nat Commun. 2022 Jan 26;13(1):517
pubmed: 35082277
Eur J Epidemiol. 2020 May;35(5):389-399
pubmed: 32430840
BMJ. 2020 Apr 24;369:m1643
pubmed: 32332028
Eur J Pers. 2020 Jul 08;:
pubmed: 32836766
Nat Hum Behav. 2020 May;4(5):460-471
pubmed: 32355299
Infect Dis Model. 2020 Apr 21;5:293-308
pubmed: 32355904
Science. 2011 May 27;332(6033):1100-4
pubmed: 21617077
Lancet Reg Health Eur. 2021 May;4:100061
pubmed: 33997831
PLoS One. 2013 Oct 23;8(10):e77952
pubmed: 24194904
Psychol Methods. 2002 Dec;7(4):422-45
pubmed: 12530702
Soc Sci Med. 2017 Jan;172:89-97
pubmed: 27914936
Int J Environ Res Public Health. 2021 Nov 17;18(22):
pubmed: 34831833
Psychol Health. 2021 Aug 02;:1-24
pubmed: 34339328
Behav Res Methods Instrum Comput. 2003 May;35(2):217-26
pubmed: 12834076

Auteurs

Svenja B Frenzel (SB)

Department of Social Psychology, Goethe University Frankfurt, Frankfurt am Main, Germany frenzel@psych.uni-frankfurt.de.

S Alexander Haslam (SA)

School of Psychology, University of Queensland, Brisbane, Queensland, Australia.

Nina M Junker (NM)

Department of Social Psychology, Goethe University Frankfurt, Frankfurt am Main, Germany.
Department of Psychology, University of Oslo, Oslo, Norway.

Aidos Bolatov (A)

Department of Biochemistry, Astana Medical University, Nur-Sultan, Kazakhstan.

Valerie A Erkens (VA)

Department of Social Psychology, Justus Liebig University Gießen, Gießen, Germany.

Jan A Häusser (JA)

Department of Social Psychology, Justus Liebig University Gießen, Gießen, Germany.

Ronit Kark (R)

Department of Psychology, Bar-Ilan University, Ramat Gan, Israel.
Business School, University of Exeter, Exeter, UK.

Ines Meyer (I)

School of Management Studies, University of Cape Town, Rondebosch, Western Cape, South Africa.

Andreas Mojzisch (A)

Psychology Department, University of Hildesheim, Hildesheim, Germany.

Lucas Monzani (L)

Ivey Business School, University of Western Ontario, London, Ontario, Canada.

Stephen D Reicher (SD)

School of Psychology and Neuroscience, University of St Andrews, St Andrews, UK.

Adil Samekin (A)

School of Liberal Arts, M Narikbayev KAZGUU University, Nur-Sultan, Kazakhstan.

Sebastian C Schuh (SC)

Organisational Behaviour and Human Resource Management, China Europe International Business School, Shanghai, China.

Niklas K Steffens (NK)

School of Psychology, University of Queensland, Brisbane, Queensland, Australia.

Liliya Sultanova (L)

Faculty of Psychology, Lomonosov Moscow State University, Branch in Tashkent, Tashkent, Uzbekistan.

Dina Van Dijk (D)

Department of Health Systems Management, Ben Gurion University of the Negev, Beer-Sheva, Israel.

Llewellyn E van Zyl (LE)

Department of Social Psychology, Goethe University Frankfurt, Frankfurt am Main, Germany.
Department of Industrial Engineering & Innovation Sciences, University of Eindhoven, Eindhoven, the Netherlands.
Optentia Research Unit, North-West University, Vanderbijlpark, South Africa.
Department of Human Resource Management, University of Twente, Enschede, the Netherlands.

Rolf van Dick (R)

Department of Social Psychology, Goethe University Frankfurt, Frankfurt am Main, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH